Ghazale Moayedian

[ 1 ] - P 65: Soluble CD18 as an Inflammation Reducing Agent in Parkinson\'s Disease

Parkinson's disease (PD) is a very common neurodegenerative disease among the elderly population. Current treatments for Parkinson’s disease are based on symptom therapy but not the underlying cause of the disease. This disorder is caused neuronal death which triggers the activation of resident glial cells. This situation leads to neuroinflammation in the central nervous system. Activated...